🏢 官网IRPRGOCodex · 实盘不做把握 9/10
北京时间·🕒 发布 20:30:00·⟳ 抓取 20:34:42 +4m42s·⚡ 决策 07-29 20:35:25 +43s·90.0 天前
Perrigo宣布将参加Canaccord年度成长会议
这只是Perrigo管理层参加投资者会议的排期通知，未披露订单、业绩指引、产品批准、资本回报或战略交易等可定价新增事实。
📄 原文PRGO↗ 原文
Perrigo to Present at the Canaccord 46th Annual Growth Conference
Press Releases Perrigo Company is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health a…
不做 Perrigo（PRGO.US）
例行投资者会议排期通知，无业绩、订单、产品、监管或资本动作等方向性增量，不形成可回测交易。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-29 · 扩散 low · price-in 风险 low ↗
关键理由
- 这只是Perrigo管理层参加投资者会议的排期通知，未披露订单、业绩指引、产品批准、资本回报或战略交易等可定价新增事实。
主要风险
- 若会议当天披露超预期经营更新，应由新的事件信号重新研判。
原文全文
展开原文 · 2,897 字
Press Releases
Perrigo Company is a leading provider of
Consumer Self-Care Products
and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.
Learn More
Presentations
Events and Webcasts
Stock Information
SEC Filings
Perrigo to Present at the Canaccord 46th Annual Growth Conference
PDF
DUBLIN
,
July 29, 2026
/
PRNewswire
/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to present at the Canaccord 46th Annual Growth Conference, on Wednesday, August 12th at 10:30 AM EDT.
The webcast can be accessed on the Perrigo website at
http://perrigo.investorroom.com/events-webcasts
.
About Perrigo
Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including
Opill
®
, Mederma
, Compeed
, EllaOne
and
Jungle Formula
For more information, visit
www.perrigo.com
Forward-Looking Statements
This press release includes, and the matters discussed in Perrigo's presentation at the Canaccord 46th Annual Growth Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at
https://investor.perrigo.com/sec-filings
, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025.
Perrigo Contacts
Eric Jacobson, Vice President, Global Investor Relations
(616) 886-0375,
eric.jacobson@perrigo.com
Nick Gallagher, Associate Director, Global Investor Relations
(269) 686-3238,
nicholas.gallagher@perrigo.com
SOURCE Perrigo Company plc
Perrigo Company is a leading provider of
Consumer Self-Care Products
and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.
Learn More
Presentations
Events and Webcasts
Stock Information
SEC Filings
Perrigo to Present at the Canaccord 46th Annual Growth Conference
DUBLIN
,
July 29, 2026
/
PRNewswire
/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to present at the Canaccord 46th Annual Growth Conference, on Wednesday, August 12th at 10:30 AM EDT.
The webcast can be accessed on the Perrigo website at
http://perrigo.investorroom.com/events-webcasts
.
About Perrigo
Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including
Opill
®
, Mederma
, Compeed
, EllaOne
and
Jungle Formula
For more information, visit
www.perrigo.com
Forward-Looking Statements
This press release includes, and the matters discussed in Perrigo's presentation at the Canaccord 46th Annual Growth Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at
https://investor.perrigo.com/sec-filings
, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025.
Perrigo Contacts
Eric Jacobson, Vice President, Global Investor Relations
(616) 886-0375,
eric.jacobson@perrigo.com
Nick Gallagher, Associate Director, Global Investor Relations
(269) 686-3238,
nicholas.gallagher@perrigo.com
SOURCE Perrigo Company plc
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。